跳至主要内容
临床试验/ISRCTN78140744
ISRCTN78140744已完成不适用

Oral nifedipine versus intravenous labetalol hydrochloride for acute blood pressure control in hypertensive emergencies of pregnancy: a double blind randomised clinical trial

niversity of Malaya Medical Centre (Malaysia)0 个研究点目标入组 50 人开始时间: 2011年3月17日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • 1. Sustained severe hypertension defined as systolic blood pressure of greater than or equal to 160 mmHg and/or diastolic blood pressure greater than or equal to 110 mmHg on at least two occasions in the last 4 hours, at least 30 minutes apart. The latest blood pressure reading must fulfil the criteria of severe hypertension.
  • 2. Medical decision to rapidly control blood pressure
  • 3. Greater than or equal to 24 weeks gestation
  • 4. Viable singleton foetus with acceptable cardiotocography (CTG)
  • 5. Maternal heart rate greater than or equal to 60 bpm and less than or equal to 120 bpm
  • 6. Aged 19 - 40 years, all pregnant females

排除标准

  • 1. Maternal history of cardiac arrhythmia
  • 2. Heart failure
  • 4. Allergy or contraindication to either nifedipine or labetalol hydrochloride
  • 5. Antihypertensive drug treatment in the last 72 hours

研究者

发起方
niversity of Malaya Medical Centre (Malaysia)

相似试验